Quantum News
Sign InSign Up
Back to News
investment

Novo Nordisk partners with OpenAI as AI drug discovery hopes mount

CNBC
Loading...
2 min read
0 likes
⚡ Quantum Brief
Danish pharmaceutical giant Novo Nordisk announced a strategic partnership with OpenAI on Tuesday to accelerate drug discovery using AI, aiming to bring treatments to patients faster by leveraging advanced data analysis. The collaboration will focus on analyzing complex biological datasets to identify promising drug candidates, particularly for obesity and diabetes, where unmet medical needs remain high, according to Novo’s CEO Mike Doustdar. OpenAI’s AI tools will enable Novo to process vast datasets at unprecedented scale, uncover hidden patterns, and test hypotheses more rapidly than traditional methods, potentially slashing drug development timelines. OpenAI CEO Sam Altman emphasized AI’s transformative role in life sciences, stating it could extend and improve lives by revolutionizing how therapies are discovered and developed. The deal underscores growing industry confidence in AI-driven drug discovery, as major pharma firms increasingly adopt machine learning to tackle diseases with high global burden.
AI Audio Summary
0:00 / 0:00
Click to play
quantum computing images.jpg
Quantum News · Media Library

Understand this faster with AI

ChatGPTAsk ChatGPTPerplexityResearch with PerplexityClaudeExplain with ClaudeGrokDiscuss on Grok

In this articleNovo Nordisk is partnering with OpenAI to "bring new and better treatment options to patients faster," the Danish drugmaker said Tuesday. The partnership will enable Novo to better use AI to analyze complex datasets, identify promising new drugs, and reduce the time it takes for a medicine to move from the research stage to patient use, the company said in a statement. "There are millions of people living with obesity and diabetes who need treatment options, and we know there are therapies still waiting to be discovered that could change their lives," said Novo CEO Mike Doustdar. "Integrating AI in our everyday work gives us the ability to analyse datasets at a scale that was previously impossible, identify patterns we could not see, and test hypotheses faster than ever.""AI is reshaping industries and in life sciences, it can help people live better, longer lives," said OpenAI CEO Sam Altman. This is breaking news. Please refresh for updates. Got a confidential news tip? We want to hear from you.Sign up for free newsletters and get more CNBC delivered to your inboxGet this delivered to your inbox, and more info about our products and services.© 2026 Versant Media, LLC.

All Rights Reserved. A Versant Media Company. Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis. Data also provided by

Read Original

Tags

drug-discovery
partnership

Source Information

Source: CNBC

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.